Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIM13 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | YOD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ANK1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | SH2D2A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | MFSD5 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | TTC38 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | GRIP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | CD163 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | CACNA1S | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |